A Phase 1B, Randomized, Placebo Controlled, Multiple Dos

Project: Research project

Project Details

Description

A Phase 1B, Randomized, Placebo Controlled, Multiple Dose Study to Evaluate the Safety of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults with Multiple Sclerosis
StatusFinished
Effective start/end date12/1/1011/30/13

Funding

  • Celgene Corporation

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.